China on Monday gave conditional approval to domestic firm Genuine Biotech's Azvudine pill to treat certain adult patients with COVID-19, adding another oral treatment option against the coronavirus.

Genuine Biotech rec'd China approval on Monday for use of HIV drug in Covid-19 treatment. ... More logo. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) ...

China's medical products regulator said on Monday it grants conditional approval to Genuine Biotech's treatment Azvudine to treat adult patients with COVID-19. The greenlight by the National ...

Genuine Biotech Co. Ltd.’s azvudine has been granted conditional approval by China’s NMPA for the treatment of COVID-19. The drug, first granted conditional approval from the NMPA to treat ...

BEIJING - China on Monday (July 25) gave conditional approval to domestic firm Genuine Biotech's Azvudine pill to treat certain adult patients with Covid-19, adding another oral treatment option ...